Robert O Williams

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 35

Top Venues

Molecular pharmaceutics

Pharmaceutics

AAPS PharmSciTech

Pharmaceutical research

University of Texas at Austin

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas at Austin Sep 01 1995

United States

Division Head :: Molecular Pharmaceutics and Drug Delivery

Publications

Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing. Molecular pharmaceutics 21 (2) (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing. Molecular pharmaceutics (2024)
Huy M Dao, Khaled AboulFotouh, Aasim Faheem Hussain, Alexander E Marras, Keith P Johnston, Zhengrong Cui, Robert O Williams
Characterization of mRNA Lipid Nanoparticles by Electron Density Mapping Reconstruction: X-ray Scattering with Density from Solution Scattering (DENSS) Algorithm. Pharmaceutical research 41 (3) (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing. Molecular pharmaceutics 21 (2) (2024)
Huy M Dao, Khaled AboulFotouh, Aasim Faheem Hussain, Alexander E Marras, Keith P Johnston, Zhengrong Cui, Robert O Williams
Characterization of mRNA Lipid Nanoparticles by Electron Density Mapping Reconstruction: X-ray Scattering with Density from Solution Scattering (DENSS) Algorithm. Pharmaceutical research 41 (3) (2024)
Huy M Dao, Khaled AboulFotouh, Aasim Faheem Hussain, Alexander E Marras, Keith P Johnston, Zhengrong Cui, Robert O Williams
Characterization of mRNA Lipid Nanoparticles by Electron Density Mapping Reconstruction: X-ray Scattering with Density from Solution Scattering (DENSS) Algorithm. Pharmaceutical research (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Correction to "Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing". Molecular pharmaceutics 21 (6) (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Correction to "Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing". Molecular pharmaceutics (2024)
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y Maier, David R Taft, Miguel O Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph W Lubach, Ajit S Narang, Karthik Nagapudi, Robert O Williams
Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing. Molecular pharmaceutics 21 (2) (2024)
Stephen A Thompson, Daniel A Davis, Dave A Miller, Sandra U Kucera, Robert O Williams
Pre-Processing a Polymer Blend into a Polymer Alloy by KinetiSol Enables Increased Ivacaftor Amorphous Solid Dispersion Drug Loading and Dissolution. Biomedicines 11 (5) (2023)
Junhuang Jiang, Xiangyu Ma, Defang Ouyang, Robert O Williams
Emerging Artificial Intelligence (AI) Technologies Used in the Development of Solid Dosage Forms. Pharmaceutics 14 (11) (2022)
Miguel O Jara, Zachary N Warnken, Sawittree Sahakijpijarn, Rishi Thakkar, Vineet R Kulkarni, Dale J Christensen, John J Koleng, Robert O Williams
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution. Pharmaceutics 14 (12) (2022)
Miguel O Jara, Zachary N Warnken, Sawittree Sahakijpijarn, Rishi Thakkar, Vineet R Kulkarni, Dale J Christensen, John J Koleng, Robert O Williams
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution. Pharmaceutics 14 (12) (2022)
Miguel O Jara, Zachary N Warnken, Sawittree Sahakijpijarn, Rishi Thakkar, Vineet R Kulkarni, Dale J Christensen, John J Koleng, Robert O Williams
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution. Pharmaceutics 14 (12) (2022)
Huy M Dao, Sawittree Sahakijpijarn, Robert R Chrostowski, Chaeho Moon, Filippo Mangolini, Zhengrong Cui, Robert O Williams
Aggregation of Lactoferrin Caused by Droplet Atomization Process via a Two-Fluid Nozzle: The Detrimental Effect of Air-Water Interfaces. Molecular pharmaceutics 19 (7) (2022)
Miguel O Jara, Zachary N Warnken, Sawittree Sahakijpijarn, Rishi Thakkar, Vineet R Kulkarni, Dale J Christensen, John J Koleng, Robert O Williams
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution. Pharmaceutics 14 (12) (2022)
Miguel O Jara, Zachary N Warnken, Robert O Williams
Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study. Pharmaceutics 13 (1) (2021)
Stephen A Thompson, Daniel A Davis, Chaeho Moon, Robert O Williams
Increasing Drug Loading of Weakly Acidic Telmisartan in Amorphous Solid Dispersions through pH Modification during Hot-Melt Extrusion. Molecular pharmaceutics (2021)
Sawittree Sahakijpijarn, Moeezullah Beg, Stephanie M Levine, Jay I Peters, Robert O Williams
A Safety and Tolerability Study of Thin Film Freeze-Dried Tacrolimus for Local Pulmonary Drug Delivery in Human Subjects. Pharmaceutics 13 (5) (2021)
Khaled AboulFotouh, Zhengrong Cui, Robert O Williams
Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration. AAPS PharmSciTech 22 (3) (2021)
Rishi Thakkar, Daniel A Davis, Robert O Williams, Mohammed Maniruzzaman
Selective Laser Sintering of a Photosensitive Drug: Impact of Processing and Formulation Parameters on Degradation, Solid State, and Quality of 3D-Printed Dosage Forms. Molecular pharmaceutics 18 (10) (2021)
Haiyue Xu, Riyad F Alzhrani, Zachary N Warnken, Sachin G Thakkar, Mingtao Zeng, Hugh D C Smyth, Robert O Williams, Zhengrong Cui
Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration. Molecular pharmaceutics 17 (9) (2020)
Yajie Zhang, BreAnne MacKenzie, John J Koleng, Esther Maier, Zachary N Warnken, Robert O Williams
Development of an Excipient-Free Peptide Dry Powder Inhalation for the Treatment of Pulmonary Fibrosis. Molecular pharmaceutics 17 (2) (2020)
Amarnath Satheesh Marudamuthu, Yashodhar Prabhakar Bhandary, Liang Fan, Vijay Radhakrishnan, BreAnne MacKenzie, Esther Maier, Shwetha Kumari Shetty, M R Nagaraja, Venkadesaperumal Gopu, Nivedita Tiwari, Yajie Zhang, Alan G Watts, Robert O Williams, Gerald J Criner, Sudhir Bolla, Nathaniel Marchetti, Steven Idell, Sreerama Shetty
Caveolin-1-derived peptide limits development of pulmonary fibrosis. Science translational medicine 11 (522) (2020)
Masataka Hanada, Scott V Jermain, Stephen A Thompson, Hirosuke Furuta, Mamoru Fukuda, Robert O Williams
Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†. Molecular pharmaceutics 18 (1) (2020)
Scott V Jermain, Michael B Lowinger, Daniel J Ellenberger, Dave A Miller, Yongchao Su, Robert O Williams
In Vitro and In Vivo Behaviors of KinetiSol and Spray-Dried Amorphous Solid Dispersions of a Weakly Basic Drug and Ionic Polymer†. Molecular pharmaceutics 17 (8) (2020)
Jieliang Wang, Ying Peng, Haiyue Xu, Zhengrong Cui, Robert O Williams
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech 21 (6) (2020)
Houli Li, Meimei Zhang, Lilong Xiong, Weiyi Feng, Robert O Williams
Bioavailability Improvement of Carbamazepine via Oral Administration of Modified-Release Amorphous Solid Dispersions in Rats. Pharmaceutics 12 (11) (2020)
Daniel A Davis, Dave A Miller, Yongchao Su, Robert O Williams
Thermally Conductive Excipient Expands KinetiSol® Processing Capabilities. AAPS PharmSciTech 21 (8) (2020)
Chaeho Moon, Alan B Watts, Xingyu Lu, Yongchao Su, Robert O Williams
Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation. Molecular pharmaceutics 16 (5) (2019)
Scott V Jermain, Dave Miller, Angela Spangenberg, Xingyu Lu, Chaeho Moon, Yongchao Su, Robert O Williams
Homogeneity of amorphous solid dispersions - an example with KinetiSol®. Drug development and industrial pharmacy 45 (5) (2019)
Chaeho Moon, Hugh D C Smyth, Alan B Watts, Robert O Williams
Delivery Technologies for Orally Inhaled Products: an Update. AAPS PharmSciTech 20 (3) (2019)
Sawittree Sahakijpijarn, Chaeho Moon, John J Koleng, Robert O Williams
Formulation Composition and Process Affect Counterion for CSP7 Peptide. Pharmaceutics 11 (10) (2019)
Michael B Lowinger, Stephanie E Barrett, Feng Zhang, Robert O Williams
Sustained Release Drug Delivery Applications of Polyurethanes. Pharmaceutics 10 (2) (2018)
Zachary N Warnken, Hugh D C Smyth, Daniel A Davis, Steve Weitman, John G Kuhn, Robert O Williams
Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts. Molecular pharmaceutics 15 (4) (2018)

Robert O Williams.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert O Williams